Axion BioSystems acquires M-Solv Manufacturing
Axion BioSystems, a company focused on advanced bioelectronic assay technologies, has acquired UK-based printed electronics manufacturer M-Solv Manufacturing Limited, a subsidiary of M-Solv Ltd.
With the acquisition the company is creating a new division, called Axion BioSystems Manufacturing, UK, Ltd., cementing the six-year partnership between the companies.
“The need to control the supply chain has never been more important,” said Tom O’Brien, CEO of Axion BioSystems, in a press release. “This vertical integration not only ensures that our customers have the products they need to conduct critical biomedical research; it also allows us to advance assay plate technologies more rapidly to meet the increasingly complex scientific demands of our users.”
Since 2017, M-Solv has supplied Atlanta-based Axion BioSystems with high-resolution proprietary printed electronics circuits, a critical consumable used in Axion’s flagship Maestro Pro multielectrode array benchtop instrument. The Maestro Pro system provides pharmaceutical companies, biotechnology firms, and research scientists with a cell analysis platform for disease modeling and drug discovery. Integrating M-Solv’s development and manufacturing team is described as a key step forward in Axion’s efforts to streamline manufacturing.
